Abramovitch Wins Phase 2 Funding for Gates Foundation Grand Challenges Round 8 Grant
- Dec 28, 2014
The Gates foundation has announced the winners of the Grand Challenges Round 8 grants
Rob’s grant is included, see below.
A Synthetic Biosensor to Find Drugs Targeting TB Persistence
Primary Investigator: Robert Abramovitch, Michigan State University, East Lansing, MI, United States, US
Topic: Apply Synthetic Biology to Global Health Challenges
Round: Round 8--May 2012
Phase: Phase 1
Robert Abramovitch of Michigan State University is in the U.S. proposes to use a synthetic biosensor strain and high-throughput screening to discover compounds that inhibit tuberculosis persistence. Study of these compounds may lead to new drugs that limit the establishment of chronic tuberculosis infections.